Download blood clot

BLO OD CLOT
AND CANCER CONNECTION
VENOUS THROMBOEMBOLISM (VTE) is a term used to describe potentially fatal blood clots that develop
in the deep veins of the body. These clots can sometimes travel to the lungs or other locations in the body.
IMPORTANT FACTS TO KNOW
Blood clots are the second
leading cause of death
AMONG PATIENTS
WITH CANCER
Patients with cancer are
up to 5 times more likely
TO GET BLOOD CLOTS
IMPACT OF CLOTS ON PATIENTS WITH CANCER
Neck
Lungs
Arms
Abdomen
74% of blood clots in
patients with cancer occur
OUTSIDE OF THE HOSPITAL
Legs
High-risk
blood clot
zones in
patients
with cancer
1
2
3
Associated with an increased risk
of tumor progression
Reduced long-term survival
Delay in critical cancer treatment
including surgery or chemotherapy
BLOOD CLOT RISK FACTORS FOR PATIENTS WITH CANCER
!
Cancer Itself
Cancer Treatments
Decreased Mobility
(Disease/Blood Changes)
(Surgery/Chemo/Hormonal)
(Hospitalization/Disease)
MEDICAL CHALLENGES
•
•
•
•
•
Highest-risk cancers
for developing VTE’s:
Stomach
Pancreatic
Brain
Lung
Lymphoma
•
•
•
•
Ovarian
Bladder
Testicular
Renal
NEW RESEARCH SEEKS A SOLUTION
Janssen, in collaboration with Bayer
HealthCare, aim to develop innovative
solutions to help reduce the burden of blood
clots on patients with cancer.
While treatments are available and recommended
in the guidelines for this high-risk patient population
in hospitals, no medicines are approved for the
primary prevention of VTE in patients with cancer
outside of the hospital.
© Janssen Pharmaceuticals, Inc. 2015
December 2015
NINE NEW STUDIES will be
conducted to examine the
prevention and treatment of
blood clots in these patients.